Skip to main content

Research Repository

Advanced Search

Observed drug-receptor association rates are governed by membrane affinity: The importance of establishing "micro-pharmacokinetic/pharmacodynamic relationships" at the ?2-adrenoceptor

Sykes, David A.; Parry, Cheryl; Reilly, John; Wright, Penny; Fairhurst, Robin A.; Charlton, Steven J.

Authors

David A. Sykes

Cheryl Parry

John Reilly

Penny Wright

Robin A. Fairhurst

Profile Image

STEVEN CHARLTON Steven.Charlton@nottingham.ac.uk
Professor of Molecular Pharmacology and Drug Discovery



Abstract

Current pharmacological models for determining affinity and kinetics of drugs for membrane receptors assume the interacting molecules are homogeneously distributed in the bulk aqueous phase. The phospholipid membrane can, however, provide a second compartment into which drugs can partition, particularly lipophilic/basic compounds. In this study we measured the phospholipid affinity and receptor binding kinetics of several clinically relevant ?2-adrenoceptor agonists and antagonists and demonstrated that the degree of phospholipid interaction directly affects the observed kinetic association rate (kon) and dissociation constant (Kd), but not the dissociation rate (koff) from the target, by concentrating drug in the local environment around the receptor. When the local drug concentration was accounted for, the kon was comparable across the cohort and the corrected Kd was directly related to the k off. In conclusion, we propose a new approach to determining the pharmacology of drugs for membrane targets that accounts for differences in local drug concentration brought about by direct affinity for phospholipids, establishing "micro-pharmacokinetic/pharmacodynamic relationships" for drugs.

Journal Article Type Article
Acceptance Date Jan 28, 2014
Online Publication Date Feb 21, 2014
Publication Date Apr 1, 2014
Deposit Date Mar 16, 2018
Journal Molecular Pharmacology
Print ISSN 0026-895X
Electronic ISSN 1521-0111
Publisher American Society for Pharmacology and Experimental Therapeutics
Peer Reviewed Peer Reviewed
Volume 85
Issue 4
Pages 608-617
DOI https://doi.org/10.1124/mol.113.090209
Keywords Molecular Medicine; Pharmacology
Public URL https://nottingham-repository.worktribe.com/output/1109907
Publisher URL http://molpharm.aspetjournals.org/content/85/4/608
PMID 00033286